Expression of Epstein-Barr virus-induced gene 3 in cervical cancer: Association with clinicopathological parameters and prognosis

Oncology Letters

Volumn 11, Issue 1, 2016, Pages 330-334

  Hou, Yan Mei ^a   Dong, Juan ^a   Liu, Ming Yuan ^a   Yu, Shan ^a  

^a Jinan Women and Children Hospital   (China)

Author keywords

Cervical cancer; Epstein Barr virus induced gene 3; Prognosis

Indexed keywords

INTERLEUKIN 35; QUANTUM DOT;

ADULT; ANTIGEN RETRIEVAL; ARTICLE; CANCER PROGNOSIS; CONTROLLED STUDY; EPSTEIN BARR VIRUS INDUCED GENE 3; FEMALE; GENE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEIOMYOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MOLECULAR IMAGING; OVERALL SURVIVAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; UTERINE CERVIX CANCER; UTERUS MYOMA;

EID: 84948823327     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2015.3849     Document Type: Article

References (23)

1. Mikami Y: Cervical cancer. Rinsho Byori 62: 596-604, 2014 (In Japanese).
2. Mirzaie-Kashani E, Bouzari M, Talebi A and Arbabzadeh-Zavareh F: Detection of human papillomavirus in chronic cervicitis, cervical adenocarcinoma, intraepithelial neoplasia and squamus cell carcinoma. Jundishapur J Microbiol 7: e9930, 2014.
3. Petry KU: Hpv and cervical cancer. Scand J Clin Lab Invest Suppl 74: 59-62, 2014.
4. Tobing MD, Sahiratmadja E, Dinda M, Hernowo BS and Susanto H: Human papillomavirus genotypes profile in cervical cancer patients at Dr. Hasan Sadikin general hospital, Bandung, Indonesia. Asian Pac J Cancer Prev 15: 5781-5785, 2014.
5. Wen Y, Pan XF, Zhao ZM, Chen F, Fu CJ, Li SQ, Zhao Y, Chang H, Xue QP and Yang CX: Knowledge of human papillomavirus (HPV) infection, cervical cancer and HPV vaccine and its correlates among medical students in Southwest China: A multi-center cross-sectional survey. Asian Pac J Cancer Prev 15: 5773-5779, 2014.
6. Devergne O, Hummel M, Koeppen H, Le Beau MM, Nathanson EC, Kieff E and Birkenbach M: A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J Virol 70: 1143-1153, 1996.
7. Niedobitek G, Päzolt D, Teichmann M and Devergne O: Frequent expression of the Epstein-Barr virus (EBV)-induced gene, Ebi3, an IL-12 p40-related cytokine, in hodgkin and reed-sternberg cells. J Pathol 198: 310-316, 2002.
8. Larousserie F, Bardel E, Pflanz S, Arnulf B, Lome-Maldonado C, Hermine O, Brégeaud L, Perennec M, Brousse N, Kastelein R and Devergne O: Analysis of interleukin-27 (EBI3/p28) expression in Epstein-barr virus-and human T-cell leukemia virus type 1-associated lymphomas: Heterogeneous expression of EBI3 subunit by tumoral cells. Am J Pathol 166: 1217-1228, 2005.
9. Larousserie F, Bardel E, Coulomb-L'Herminé A, Canioni D, Brousse N, Kastelein RA and Devergne O: Variable expression of Epstein-Barr virus-induced gene 3 during normal B-cell differentiation and among B-cell lymphomas. J Pathol 209: 360-368, 2006.
10. Nishino R, Takano A, Oshita H, Ishikawa N, Akiyama H, Ito H, Nakayama H, Miyagi Y, Tsuchiya E, Kohno N, et al: Identification of Epstein-Barr virus-induced gene 3 as a novel serum and tissue biomarker and a therapeutic target for lung cancer. Clin Cancer Res 17: 6272-6286, 2011.
11. Zeng JC, Zhang Z, Li TY, Liang YF, Wang HM, Bao JJ, Zhang JA, Wang WD, Xiang WY, Kong B, et al: Assessing the role of IL-35 in colorectal cancer progression and prognosis. Int J Clin Exp Pathol 6: 1806-1816, 2013.
12. Gonin J, Larousserie F, Bastard C, Picquenot JM, Couturier J, Radford-Weiss I, Dietrich C, Brousse N, Vacher-Lavenu MC and Devergne O: Epstein-Barr virus-induced gene 3 (EBI3): A novel diagnosis marker in Burkitt lymphoma and diffuse large B-cell lymphoma. PLoS One 6: e24617, 2011.
13. Chen C, Peng J, Xia HS, Yang GF, Wu QS, Chen LD, Zeng LB, Zhang ZL, Pang DW and Li Y: Quantum dots-based immunofluorescence technology for the quantitative determination of HER2 expression in breast cancer. Biomaterials 30: 2912-2918, 2009.
14. Chen C, Xia HS, Gong YP, Peng J, Peng CW, Hu MB, Zhu XB, Pang DW, Sun SR and Li Y: The quantitative detection of total HER2 load by quantum dots and the identification of a new subtype of breast cancer with different 5-year prognosis. Biomaterials 31: 8818-8825, 2010.
15. Poleganov MA, Bachmann M, Pfeilschifter J and Mühl H: Genome-wide analysis displays marked induction of EBI3/IL-27B in IL-18-activated AML-derived KG1 cells: Critical role of two kappaB binding sites in the human EBI3 promotor. Mol Immunol 45: 2869-2880, 2008.
16. Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, Cross R, Sehy D, Blumberg RS and Vignali DA: The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450: 566-569, 2007.
17. Collison LW, Pillai MR, Chaturvedi V and Vignali DA: Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35-and IL-10-dependent manner. J Immunol 182: 6121-6128, 2009.
18. Collison LW, Chaturvedi V, Henderson AL, Giacomin PR, Guy C, Bankoti J, Finkelstein D, Forbes K, Workman CJ, Brown SA, et al: IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 11: 1093-1101, 2010.
19. Seyerl M, Kirchberger S, Majdic O, Seipelt J, Jindra C, Schrauf C and Stöckl J: Human rhinoviruses induce IL-35-producing Treg via Induction of B7-H1 (CD274) and sialoadhesin (CD169) on DC. Eur J Immunol 40: 321-329, 2010.
20. Chaturvedi V, Collison LW, Guy CS, Workman CJ and Vignali DA: Cutting edge: Human regulatory T cells require IL-35 to mediate suppression and infectious tolerance. J Immunol 186: 6661-6666, 2011.
21. Li X, Mai J, Virtue A, Yin Y, Gong R, Sha X, Gutchigian S, Frisch A, Hodge I, Jiang X, et al: IL-35 is a novel responsive anti-inflammatory cytokine-a new system of categorizing anti-inflammatory cytokines. PLoS One 7: e33628, 2012.
22. Long J, Zhang X, Wen M, Kong Q, Lv Z, An Y and Wei XQ: IL-35 over-expression increases apoptosis sensitivity and suppresses cell growth in human cancer cells. Biochem Biophys Res Commun 430: 364-369, 2013.
23. Devergne O, Birkenbach M and Kieff E: Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc Natl Acad Sci USA 94: 12041-12046, 1997.